Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
The Print on MSN
Health ministry eases drug trial rules. Test licences scrapped, CDSCO approval timelines cut by half
Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, ...
The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory processes and reduction of drug approval timelines to facilitate and speed up the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results